Document is current
Any future updates will be listed below
-
Authors
Xu, Ailing
Pan, Nifang
Zhang, Bibo
Liu, Xuan
Sheng, Yuefeng
Deng, Yimai
Wu, Zhenghao
Wu, Shuyan
-
Funding
Funding for this research was provided by:
Medical Innovation Application Research Project of Soochow Science and Technology Bureau (SKY2023086)
“National Mentoring System” Training Program for Young Talents in the Soochow Healthcare Field (Qngg2023036)
National Natural Science Foundation of China (32270187)
Priority Academic Program Development of Jiangsu Higher Education Institutions
- License Information
-
More Information
Article History
Received: 13 October 2025
Accepted: 11 December 2025
First Online: 20 December 2025
Declarations
:
: Ethical approval for the collection of Mycolicibacterium houstonense hospital isolates and background clinical data was obtained from the Medical Ethics Committee of Changshu Hospital Affiliated to Soochow University, Changshu NO.1 People’s Hospital, Jiangsu, China, with approval number L2025037. This study was conducted in accordance with Helsinki Declaration. According to the Changshu Hospital Affiliated to Soochow University Medical Ethics Committee, informed consent was deemed unnecessary because the isolate was obtained from residual pus specimens remaining after the completion of clinical microbiological testing of hospitalized patients.
: Not applicable.
: The authors declare no competing interests.
